Integra Lifesciences Holdings (IART) Liabilities from Discontinued Operations (2014 - 2022)
Integra Lifesciences Holdings (IART) reported Liabilities from Discontinued Operations of 2303000.0 for Q2 2022, down 80.4% sequentially from 11751000.0 in Q4 2020.
Integra Lifesciences Holdings (IART) Liabilities from Discontinued Operations (2014 - 2022) Analysis & Trends
Integra Lifesciences Holdings (IART) has 3 years of Liabilities from Discontinued Operations data on file, last reported at 2303000.0 in Q2 2022.
- For the quarter ending Q2 2022, Liabilities from Discontinued Operations changed N/A year-over-year to 2303000.0; the trailing twelve-month figure through Jun 2022 stood at 2303000.0 (changed N/A YoY), and the FY2020 full-year result was 11751000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations declined to 2303000.0 in Q2 2022, from 11751000.0 in the prior quarter.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of 12349000.0 in Q3 2020 to a low of 2303000.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Integra Lifesciences Holdings | 1.71 Bn | 1.45 Bn | 216.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 2.30 Mn |
| Jun 30, 2022 | 2.30 Mn |
| Dec 31, 2020 | 11.75 Mn |
| Dec 31, 2020 | 11.75 Mn |
| Sep 30, 2020 | 12.35 Mn |
| Sep 30, 2020 | 12.35 Mn |
| Dec 31, 2014 | 2.63 Mn |
| Dec 31, 2014 | 2.63 Mn |